GH Research PLC
GHRS · XNASCIK 1855129fmd_1DD5D9W0YXG9AF4T0ZWS7BAB15Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2019 to Dec 31, 2025, 18 periods
Latest annual · FY2025
Millions- Operating income
- (61)
- Net income
- (48)
Latest quarter · Q4 FY2025
Millions- Operating income
- (17)
- Net income
- (14)
- Free cash flow
- (12)
Key stats
Open AnalysisCompound annual growth
- Net income, 5 yearsFY2020 to FY2025
- n/m
GH Research PLC (GHRS) financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2025 | FY2024 | Change | Source |
|---|---|---|---|---|
| Operating income | -$60.7 million | -$50.3 million | 20-F 2026-03-05 · proof | |
| Net income | -$48.3 million | -$39 million | 20-F 2026-03-05 · proof | |
| Cash from operating activities | -$43.6 million | -$42.3 million | 20-F 2026-03-05 · proof | |
| Free cash flow | -$43.7 million | -$42.3 million | 20-F 2026-03-05 · proof | |
| Total assets | $288.2 million | $188.3 million | +53.1% | 20-F 2026-03-05 · proof |
| Total liabilities | $8.5 million | $9.3 million | -8.5% | 20-F 2026-03-05 · proof |
| Cash and cash equivalents | $246.3 million | $100.8 million | +144.3% | 20-F 2026-03-05 · proof |
- What was GH Research PLC (GHRS)'s operating income in fiscal 2025?
- GH Research PLC (GHRS) reported operating income of -$60.7 million for fiscal 2025 (the year ended Dec 31, 2025), against -$50.3 million the year before. Source: the 20-F filed with the SEC on Mar 5, 2026. SEC
- What was GH Research PLC (GHRS)'s net income in fiscal 2025?
- GH Research PLC (GHRS) reported net income of -$48.3 million for fiscal 2025 (the year ended Dec 31, 2025), against -$39 million the year before. Source: the 20-F filed with the SEC on Mar 5, 2026. SEC
- What was GH Research PLC (GHRS)'s cash from operating activities in fiscal 2025?
- GH Research PLC (GHRS) reported cash from operating activities of -$43.6 million for fiscal 2025 (the year ended Dec 31, 2025), against -$42.3 million the year before. Source: the 20-F filed with the SEC on Mar 5, 2026. SEC
- What was GH Research PLC (GHRS)'s free cash flow in fiscal 2025?
- GH Research PLC (GHRS) reported free cash flow of -$43.7 million for fiscal 2025 (the year ended Dec 31, 2025), against -$42.3 million the year before. Source: the 20-F filed with the SEC on Mar 5, 2026. SEC
- What are GH Research PLC (GHRS)'s total assets?
- As of Dec 31, 2025, GH Research PLC (GHRS) reported total assets of $288.2 million, against $188.3 million a year earlier (+53.1%). Source: the 20-F filed with the SEC on Mar 5, 2026. SEC
- What are GH Research PLC (GHRS)'s total liabilities?
- As of Dec 31, 2025, GH Research PLC (GHRS) reported total liabilities of $8.5 million, against $9.3 million a year earlier (-8.5%). Source: the 20-F filed with the SEC on Mar 5, 2026. SEC
- What are GH Research PLC (GHRS)'s cash and cash equivalents?
- As of Dec 31, 2025, GH Research PLC (GHRS) reported cash and cash equivalents of $246.3 million, against $100.8 million a year earlier (+144.3%). Source: the 20-F filed with the SEC on Mar 5, 2026. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=ticker:GHRS&period_type=annual&limit=5"Information only, not investment advice.